Skip to main content


Figure 2 | Lipids in Health and Disease

Figure 2

From: Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study

Figure 2

Negligible effect of daily dose of V-6 on body mass index (BMI; -0.4%; p = 0.21) as opposed to statistically significant reduction in waist (-3.8%; p = 0.008), mid-arm (-3.9%; p = 0.004), and thigh (-5.3%; p = 0.0007) circumferences as followed through weeks 2, 4, and 8. Individual values from each time-point for every patient are plotted and mean values are shown as bold line.

Back to article page